Table 2. Review of M. leprae SNP types previously described in different countries.

WHO Region	Country	SNP type 1		SNP type 2		SNP type 3		SNP type 4
			Total		Total		Total		Total
African	Mali							31[6]+1§	32
	Sénégal							2[6]	2
	Guinea							1[6]+2§	3
	Ivory Coast*					1§	1	6[6]	6
	Benin*							1§	1
	Congo*	3§	3					1§	1
	Ethiopia			2[6]	2
	Malawi	4[6]	4	6[6]	6
	Comoros *	16§	16
	Mayotte *	5§	5
	Madagascar	6[6]+1§	7
	La Reunion *					1§	1
American	United States					3[6]	3
	Mexico	6[21]	6	13[21]	13	45[21]+1[6]	46
	Venezuela					5[6]	5
	Brazil	4[22]	4			37[22]+12[6]	49	46[22]+2[6]+1§	49
	Haiti*							1§	1
	French West Indies *	4[6] +1§	5			2[6]	2	14[6]+3§	17
	Bolivia, Brazil, Uruguay, Venezuela	16[23]	16			172[23]	172	45[23]	45
South East Asia	Korea	3[6]+15[24]	18	4[24]	4	2[6]+17[24]+7[25]	26
	India	166[26]+27[6]+11[14]+45[15]+1§	250	14[26]+5[6]	19
	Sri Lanka*	1§	1
	Indonesia	12[24]	12	7[24]+1[25]	8	16[24]	16
	Myanmar	26[24]	26	1[24]	1	2[24]	2
	Thailand	1[6]+2[25]+68[27]	71			17[27]	17
Eastern Mediterranean	Morocco					2[6]	2
Western Pacific	China	18[28]	18	1[28]	1	82[28]	82
	Japan	1[25] +4[24]	5	2[24]	2	16[25]+47[24]	63	2[24]	2
	Philippines	19[6]+ 175[29]	194	6[25]	6	2[6]+ 32[29]	34
	New Caledonia	3[6]+3§	6	1[6] +6§	7	3[6] +11§	14	1§	1
	French Polynesia *					4§	4

* Indicates countries for which no previous SNP data were available

§ countries/territories covered in this study

French overseas territories are underlined

Concerning Congo: one patient was born in DRC, one patient was born in RC, one patient was born in France but has lived in DRC and one patient was born in France but has lived in Congo (without further information).